In patients with pre-existing CMV immunity (positive IgG), a significant rise in CMV-IgG (and high CMV-IgG avidity) and/or the presence of CMV-IgM often lead clinicians to suspect a CMV non-primary infection (NPI). This evidence concerns the gene CD40LG and infection.